Cerexin B4
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-00519 |
| CAS | 70943-84-9 |
| Molecular Weight | 1392.59 |
| Molecular Formula | C66H101N15O18 |
Online Inquiry
Description
It is produced by the strain of Bacillus cereus. It has anti-gram-positive bacterial activity.
Specification
| IUPAC Name | (2R,3S)-2-[[(2R)-2-[[2-[[(2R,3R)-2-[[(2S,4R)-6-amino-2-[[(2R)-4-amino-2-[[(2S)-4-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-4-amino-2-[(3-hydroxy-9-methyldecanoyl)amino]-4-oxobutanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-4-oxobutanoyl]amino]-4-hydroxyhexanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoic acid |
| Canonical SMILES | CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC(CCN)O)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)C)NC(=O)C(CC(=O)N)NC(=O)CC(CCCCCC(C)C)O |
| InChI | InChI=1S/C66H101N15O18/c1-8-36(6)56(66(98)99)80-61(93)45(26-39-32-71-43-22-16-15-21-42(39)43)74-54(89)33-72-64(96)57(37(7)82)81-62(94)46(27-41(84)23-24-67)75-59(91)48(30-51(69)86)77-60(92)49(31-52(70)87)76-58(90)44(25-38-18-12-10-13-19-38)78-65(97)55(35(4)5)79-63(95)47(29-50(68)85)73-53(88)28-40(83)20-14-9-11-17-34(2)3/h10,12-13,15-16,18-19,21-22,32,34-37,40-41,44-49,55-57,71,82-84H,8-9,11,14,17,20,23-31,33,67H2,1-7H3,(H2,68,85)(H2,69,86)(H2,70,87)(H,72,96)(H,73,88)(H,74,89)(H,75,91)(H,76,90)(H,77,92)(H,78,97)(H,79,95)(H,80,93)(H,81,94)(H,98,99)/t36-,37+,40?,41+,44+,45+,46-,47+,48+,49-,55+,56+,57+/m0/s1 |
| InChI Key | BJUDIRCOMXHHOB-LXMMGXMPSA-N |
Properties
| Antibiotic Activity Spectrum | Gram-positive bacteria |
Reference Reading
1. Resolution of peptide antibiotics, cerexins and tridecaptins, by high performance liquid chromatography (studies on antibiotics from the genus Bacillus. XXVI)
J Shoji, T Kato, S Terabe, R Konaka J Antibiot (Tokyo). 1979 Apr;32(4):313-9. doi: 10.7164/antibiotics.32.313.
By high performance liquid chromatography, cerexin B was separated into four components (B1, B2, B3 and B4), cerexin D into four components (D1, D2, D3 and D4), tridecaptin A into components (A alpha and A beta), tridecaptin B into four components (B alpha, B beta, B gamma and B delta) and tridecaptin C into three components (C alpha 1, C alpha 2 and C beta 1). All components were preparatively isolated, and their fatty acid and amino acid compositions determined for structural elucidation.
Recommended Products
| BBF-02614 | Nystatin | Inquiry |
| BBF-01693 | Doxorubicin EP Impurity A (Daunorubicin) | Inquiry |
| BBF-01825 | Loganin | Inquiry |
| BBF-01826 | Deoxymannojirimycin | Inquiry |
| BBF-03755 | Actinomycin D | Inquiry |
| BBF-05862 | Epirubicin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
